Skip to Content Skip to Footer
John Andraos, PharmD, APh

John Andraos, PharmD, APh

Assistant Professor

College of Pharmacy

jandraos@westernu.edu

  • Education
    • PharmD 2019, Chapman University School of Pharmacy
    • Pharmacy-Based Travel Medicine, American Pharmacist’s Association, 2019
    • Teaching Certificate, Chapman University School of Pharmacy, 2020
    • APh (Advanced Practice Pharmacist), 2022
  • Education Experience
    • PGY1 Residency Ambulatory Care Focused Pharmacy Practice 2020, Cedars-Sinai Medical Network/Chapman University School of Pharmacy
    • PGY2 Ambulatory Care (Endocrinology) and Academia Focused 2021, Cedars-Sinai Medical Network/Chapman University School of Pharmacy
  • Professional Experience
    • Clinical Pharmacist, Resident Coordinator, Cedars Sinai Medical Network 2021-2022
    • Adjust Assistant Professor of Pharmacy, Chapman University School of Pharmacy 2019-2022
    • Adjust Assistant Professor of Pharmacy, Touro University California College of Pharmacy, 2021-2022
  • Awards
    • CSHP Innovating Pharmacy Practice Award, 2020
    • CUSP Resident Teacher of the Year Award, 2019-2020
    • American Association of Colleges of Pharmacy Walmart Scholar, 2019
  • Organizations
    • Phi Delta Chi
    • Phi Lamda Sigma
    • Rho Chi
  • Publications
    • Zeiger A, Andraos J, Sharma A, Roosan M. “Pharmacogenomic Considerations in Opioid Therapy”. U.S. Pharmacist. April 2022.
    • John Andraos, Luma Munjy &; Michael S. Kelly (2021): Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations, Blood Pressure, DOI: 10.1080/08037051.2021.1911622
    • Kelly M, Andraos J, Zeiger A. “Is dapagliflozin aDAPtAble to treating reduced EF heart failure?” iForumRx commentary, podcast on DAPA-HF trial. December 2019.
    • Munjy L, Bethishou L, Andraos J. “Shingrix Revaccination and Vaccination in Vulnerable Populations”. Pharmacy Times. March 2019.